US Anticoagulation Therapy Market to 2022 “Led by Abbott (US), Siemens (Germany) and Roche (Switzerland)

Growth in anticoagulation drugs market is primarily driven by the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs).

Download Free Sample Copy of US Anticoagulation Therapy Market spread across 86 Pages, Profiling 6 Companies and Supported with 29 Tables and 25 Figures is now available at http://www.reportsnreports.com/contacts/requestsample.aspx?name=1226231 .

US anticoagulation therapy market is projected to reach USD 27.83 Billion by 2022 from USD 17.25 Billion in 2016, at a CAGR of 8.5%. Market is segmented into products (anticoagulation drugs & PT/INR testing devices) & anticoagulation clinics. In addition, growth of anticoagulation clinics market is primarily driven by increasing prevalence of cardiovascular diseases & blood disorders, high level of medication adherence associated with clinics, & rising aging population.

Target Audience:

• Healthcare service providers
• Healthcare service payers/insurance payers
• Pharmaceutical companies
• Medical device companies
• Venture capitalists
• Government bodies
• Business research and consulting firms

US anticoagulation therapy market study tracks & analyzes competitive developments (like new product developments & R&D activities) & profiles key players in US anticoagulation therapy market. US anticoagulation therapy market in report segmented by products & clinics. It provides detailed information regarding major factors influencing growth market (drivers, restraints, & industry-specific opportunities).

Click here for More Information on This Research Report at https://www.medgadget.com/2017/12/medical-news-on-us-anticoagulation-therapy-market-to-2022-growth-driven-by-venous-thromboembolism-trial-fibrillation-and-strokes.html .

Market players such as C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US anticoagulation therapy market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US anticoagulation therapy market for PT/INR home testing devices.

Anticoalulation Market Insights

• Introduction
• Number of Anticoagulation Clinics
• Business Models of Anticoagulation Clinics
• Reimbursement Scenario (CMS & Private Payers)
• Impact of New Oral Anticoagulants (Noacs) on Anticoagulation Clinics